News
The National Agency for Food and Drug Administration and Control (NAFDAC) has raised a public health alert over the circulation ...
President Bola Ahmed Tinubu has called for a collective national effort in combating substance abuse and illicit drug ...
7h
TipRanks on MSNAstraZeneca’s New Study on AZD5492: A Potential Game-Changer for Autoimmune DiseasesAstraZeneca has launched a Phase I clinical study titled An Open-label, Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 Followi ...
The US Food and Drug Administration (FDA) has approved the belimumab 200 mg/mL autoinjector for children aged 5 years of older with active lupus nephritis (LN) who are receiving standard therapy.
Benlysta is supplied as a single-dose prefilled autoinjector or prefilled syringe containing 200mg/mL of belimumab for SC use. The prefilled syringe has not been studied in pediatric patients aged ...
A team of doctors at Michigan Medicine have successfully treated a child in severe septic shock and multiorgan failure with ...
Detalimogene voraplasmid gains FDA RMAT designation, showcasing a 71% response rate in treating high-risk, BCG-unresponsive ...
The U.S. Treasury accuses CIBanco and Intercam Banco of money laundering and facilitating payments related to fentanyl.
The Food Safety and Standards Act, 2006 (FSS Act) marked a significant overhaul of India’s food regulatory landscape, bringing together many outdated and overla ...
Finding an effective, safe medication to control itch is essential to maximize patient comfort. Because Zenrelia does not require a loading dose and is administered once daily, Zenrelia may help impro ...
What’s really happening across Africa right now? From unexpected political twists and bold peacekeeping moves to ...
Merck, a leading science and technology company, today announced the presentation of detailed results from Cohort B of the global Phase 2 WILLOW study (NCT05162586) evaluating enpatoran, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results